New analysis shows corrected T1 (cT1) is the most appropriate diagnosis and monitoring tool for widespread adoption of resmetirom treatment in the United States
September 3, 2025
UK Biobank Completes World’s Largest Human Imaging Study
August 15, 2025
Marea Therapeutics Publishes Phase 2 Trial Results in The Lancet
July 8, 2025
Major Study Shows Liver Health Measured with cT1 Predicts Clinical Outcomes
May 7, 2025
New Multinational Study Shows MRI is Cost-Effective in the Diagnosis and Management of Steatotic Liver Disease
March 18, 2025
Perspectum Awarded New FDA Grant to Evaluate Biomarker for Rare Disease Drug Development
November 14, 2024
CoverScan, Perspectum’s multi-organ MRI technology, has been nominated for the 2024 Prix Galien USA award for Best Digital Health Solution.
October 30, 2024
New Published Data Show Reproducibility and Utility of Perspectum’s MRI in Patients With Metabolic Liver Disease
September 26, 2024
Dr Rajarshi Banerjee joins Amrita Sarkar, Principal Healthcare and Life Sciences Startups Business Development manager in this episode of the AWS Health Innovation Podcast.
August 27, 2024
